"It's a gateway drug. Eventually it won't get you high any more, and you're going to look for something greater. It tears ...

Despite this, one in five young adults who meet the criteria for the drugs are uninsured and one-third denied having a routine place for healthcare.

Odyssey House, one of the largest drug treatment centers in the city, is spending tens of millions of dollars to build a new ...

A group of scientists has confirmed the efficacy of a new oral anti-viral treatment, called CP-COV03 or Xafty, against ...

How political red tape and a drug company’s thirst for profits limited the reach of a drug that experts believe could have ...

FDA accelerates approval of dordaviprone, the first targeted therapy for aggressive diffuse midline glioma, offering hope for ...

With the implementation of changes from President Trump’s “Big Beautiful Bill,” public assistance programs may impose rules ...

A new study suggests a method known as "regulation of cues" could be more effective than cognitive behavioral therapy in ...

In a press release, the National Institute for Health and Care Excellence announced the first-ever approval for a ...

Young adults without jobs that provide insurance find that their options are limited and expensive. The problem is about to get worse.

Gaps in data and long-term research about the safety of smokeless products raise questions about whether the means will truly ...

Senhwa Biosciences, Inc. (TPEx: 6492), a new drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today announced that US National ...